119 related articles for article (PubMed ID: 34897776)
1. Synthesis of novel hybrid pharmacophore of N-((4-sulfamoylphenyl)carbamothioyl)alkanamides as potent carbonic anhydrase-II and 15-lipoxygenase inhibitors.
Saeed A; Khan SU; Saeed M; Shabir G; Hasan A; Khera RA; El-Seedi H; Halim SA; Khan A; Al-Harrasi A; Iqbal J
Drug Dev Res; 2022 May; 83(3):745-754. PubMed ID: 34897776
[TBL] [Abstract][Full Text] [Related]
2. Substituted (E)-2-(2-benzylidenehydrazinyl)-4-methylthiazole-5-carboxylates as dual inhibitors of 15-lipoxygenase & carbonic anhydrase II: synthesis, biochemical evaluation and docking studies.
Saeed A; Khan SU; Mahesar PA; Channar PA; Shabir G; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(1):176-181. PubMed ID: 27836541
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Biological Evaluation, and Molecular Dynamics of Carbothioamides Derivatives as Carbonic Anhydrase II and 15-Lipoxygenase Inhibitors.
Channar PA; Alharthy RD; Ejaz SA; Saeed A; Iqbal J
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557863
[TBL] [Abstract][Full Text] [Related]
4. New aminobenzenesulfonamide-thiourea conjugates: synthesis and carbonic anhydrase inhibition and docking studies.
Zaib S; Saeed A; Stolte K; Flörke U; Shahid M; Iqbal J
Eur J Med Chem; 2014 May; 78():140-50. PubMed ID: 24681391
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory Efficacy of Thiosemicarbazones for Carbonic Anhydrase II (Bovine and Human) as a Target of Calcification and Tumorigenicity.
Khan M; Halim SA; Shafiq Z; Islam M; Shehzad MT; Ibrar A; Khan FA; Marraiki N; Uddin J; Khan A; Al-Harrasi A
Curr Pharm Des; 2022; 28(36):3010-3022. PubMed ID: 35909284
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibition by 1-aroyl-3-(4-aminosulfonylphenyl)thioureas.
Saeed A; Al-Rashida M; Hamayoun M; Mumtaz A; Iqbal J
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):901-5. PubMed ID: 24666305
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of Cancer.
Ahmed A; Aziz M; Ejaz SA; Channar PA; Saeed A; Zargar S; Wani TA; Hamad A; Abbas Q; Raza H; Kim SJ
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421710
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors.
Turkan F; Cetin A; Taslimi P; Karaman M; Gulçin İ
Bioorg Chem; 2019 May; 86():420-427. PubMed ID: 30769267
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, carbonic anhydrase inhibitory activity and antioxidant activity of some 1,3-oxazine derivatives.
Qamar R; Saeed A; Saeed M; Ashraf Z; Abbas Q; Hassan M; Albericio F
Drug Dev Res; 2018 Nov; 79(7):352-361. PubMed ID: 30302774
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Molecular Docking Study of Novel 3-Phenyl-β-Alanine-Based Oxadiazole Analogues as Potent Carbonic Anhydrase II Inhibitors.
Rafiq K; Ur Rehman N; Halim SA; Khan M; Khan A; Al-Harrasi A
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164091
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties.
Altug C; Güneş H; Nocentini A; Monti SM; Buonanno M; Supuran CT
Bioorg Med Chem; 2017 Feb; 25(4):1456-1464. PubMed ID: 28111158
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors.
Askin S; Tahtaci H; Türkeş C; Demir Y; Ece A; Akalın Çiftçi G; Beydemir Ş
Bioorg Chem; 2021 Aug; 113():105009. PubMed ID: 34052739
[TBL] [Abstract][Full Text] [Related]
13. New Carbonic Anhydrase-II Inhibitors from Marine Macro Brown Alga
Rafiq K; Khan A; Ur Rehman N; Halim SA; Khan M; Ali L; Hilal Al-Balushi A; Al-Busaidi HK; Al-Harrasi A
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885658
[TBL] [Abstract][Full Text] [Related]
14. Utilization of the common functional groups in bioactive molecules: Exploring dual inhibitory potential and computational analysis of keto esters against α-glucosidase and carbonic anhydrase-II enzymes.
Khan I; Khan A; Halim SA; Khan M; Zaib S; Al-Yahyaei BEM; Al-Harrasi A; Ibrar A
Int J Biol Macromol; 2021 Jan; 167():233-244. PubMed ID: 33249154
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of sulfonamide, amide and amine hybrid pharmacophore, an entry of new class of carbonic anhydrase II inhibitors and evaluation of chemo-informatics and binding analysis.
Ahmed A; Channar PA; Saeed A; Kalesse M; Kazi MA; Larik FA; Abbas Q; Hassan M; Raza H; Seo SY
Bioorg Chem; 2019 May; 86():624-630. PubMed ID: 30807935
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors.
Mahmood SU; Saeed A; Bua S; Nocentini A; Gratteri P; Supuran CT
Bioorg Chem; 2018 Apr; 77():381-386. PubMed ID: 29421714
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and investigation of inhibition effect of fluorinated sulfonamide derivatives on carbonic anhydrase.
Benfodda Z; Guillen F; Romestand B; Dahmani A; Blancou H
Eur J Med Chem; 2010 Mar; 45(3):1225-9. PubMed ID: 20036446
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and docking studies of novel thiourea derivatives of bisindolylmethane as carbonic anhydrase II inhibitor.
Imran S; Taha M; Ismail NH; Fayyaz S; Khan KM; Choudhary MI
Bioorg Chem; 2015 Oct; 62():83-93. PubMed ID: 26275866
[TBL] [Abstract][Full Text] [Related]
19. Sulfonamides containing curcumin scaffold: Synthesis, characterization, carbonic anhydrase inhibition and molecular docking studies.
Ahmed M; Qadir MA; Hameed A; Arshad MN; Asiri AM; Muddassar M
Bioorg Chem; 2018 Feb; 76():218-227. PubMed ID: 29190478
[TBL] [Abstract][Full Text] [Related]
20. Sulfonamides incorporating ketene N,S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors.
Istrefi Q; Türkeş C; Arslan M; Demir Y; Nixha AR; Beydemir Ş; Küfrevioğlu ÖI
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900383. PubMed ID: 32285537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
